The partners will use 4D Path's imaging-based Q-Plasia OncoReader in a Phase II trial testing doublet and triplet regimens comprising Trodelvy, Padcev, and Keytruda.
Federal Reserve Chair Jerome Powell kicks off his post-meeting press conference by saying the outlook for employment and inflation haven’t changed much since the October FOMC meeting, even with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback